OTTAWA, Feb. 27 /CNW Telbec/ - The Juvenile Diabetes Research Foundation
(JDRF) expressed disappointment that it was not included in Budget 2008 and
said it will continue advocating for the funds required to establish an
innovative partnership with the Canadian Institute of Health Research (CIHR)
to create a clinical trial network for research into Type 1 diabetes.
"Following an intensive proposal process, we are disappointed to be left
out of this year's federal budget, and the delay in the opportunity to launch
the next stage of Canada's leadership in diabetes research," said Andrew
McKee, President and Chief Executive Officer of JDRF. "We understand the
government of Canada has many demands on its programming priorities, but we
will continue to make the establishment of a clinical trial network for
research into Type 1 diabetes a priority on behalf of Canadians living with
"This novel approach of partnering with CIHR is the first of its kind
where a non-governmental organization and federal government agency would
jointly fund research to support a clinical trial network," said Mr. McKee.
The network would create a new class of capital investment to accelerate and
leverage gains in Canadian research, development and commercialized delivery.
The funding partnership would be phased in over five years, with the objective
of creating a CIHR Clinical Trial Network with JDRF as the incubation project.
In the first five years, JDRF will contribute $50 million to Type 1 diabetes
research in Canada. JDRF has already created successful clinical trial
networks in Australia and the United States.
The clinical trial network will serve as a model for other diseases, and
will help researchers reduce the incidence and prevalence of Type 1 diabetes;
implement clinical trial validated best practices; provide clinical trial
innovation and management; and facilitate a national knowledge analysis, data
and technology network.
Type 1 diabetes is a non-preventable autoimmune disease that is the most
severe form of diabetes. It strikes infants, children and young adults and
leaves them dependent on insulin for life with the constant threat of
developing complications such as kidney failure, blindness, nerve damage,
lower limb amputations, heart attacks and strokes.
About Juvenile Diabetes Research Foundation:
Juvenile Diabetes Research Foundation (JDRF) is the leading charitable
funder and advocate of Type 1 diabetes research worldwide. The mission of JDRF
is to find a cure for diabetes and its complications through the support of
research. JDRF funding and leadership is associated with most major scientific
breakthroughs in Type 1 research to date. In fact, JDRF is the largest
non-governmental source of Type 1 diabetes research funding worldwide. The
Foundation is structured on a business-world model that efficiently and
effectively directs resources to research aimed at finding a cure as soon as
For further information:
For further information: Jennifer Paul, National Director, Marketing and
Communications, Juvenile Diabetes Research Foundation, (905) 944-4625,